JPH09224608A - Agent for suppressing lipid storage - Google Patents

Abstract

PROBLEM TO BE SOLVED: To obtain a lipid storage suppressing agent containing a natural polysaccharide as an active ingredient. SOLUTION: Xyloglucan, preferably xyloglucan originated from easily available tamarind seed has remarkable lipid storage suppressing action. Obesity, hyperlipemia, fatty liver, etc., can be prevented or cured by continuously taking a food incorporated with the substance.

Description

Detailed Description of the Invention

[0001]

TECHNICAL FIELD The present invention relates to a lipid increase inhibitor containing xyloglucan as an active ingredient.

[0002]

2. Description of the Related Art In recent years, in advanced industrialized countries including Japan, excessive intake of energy and lipid, which are products of "abundance", causes obesity, hyperlipidemia, diabetes and hypertension. One of the causes of serious diseases in
It has become a serious problem for health. Furthermore, obesity and hyperlipidemia are risk factors for cardiovascular diseases, and are also strongly associated with gout, gallstone disease, liver disease and the like.

Recently, particularly among young women, the consciousness of obesity is hypersensitivity, which causes problems such as excessive dieting and upset nutritional balance.

[0004] As a means for treating and preventing obesity and hyperlipidemia, conventionally, dietary intake is restricted, dietary contents are changed to low calorie or low fat, and calorie intake is reduced. To increase calories burned, or to ingest physiologically active substances derived from drugs and food ingredients. However, reducing the calorie intake and increasing the calorie consumption impairs a comfortable diet for a long period of time, and requires proper guidance and a strong will and is actually quite difficult. Taking drugs has side effects and costs. Also, physiologically active substances derived from food ingredients,
For example, certain natural polysaccharides such as pectin and guar gum (for example, "Dietary Fiber", First Publication, edited by Shuhachi Kiriyama), Baiyaki Dextrin (JP-A-3-247258), branched fatty acids (JP-A-3-247258). ), Lipase inhibitor (Japanese Patent Laid-Open No. 4-327536), the flavor and texture at the time of ingestion are impaired, and even if ingested, the effectiveness is low, and a large amount of ingestion is required, and sometimes, it is slow. Side effects such as subordinate effects occur. However, since ingesting physiologically active substances derived from food ingredients is a simple means, in the food industry in particular, effective natural materials that can be ingested deliciously with meals and have a preventive meaning against obesity are found. Is desired. The present invention is to provide such an effective natural material.

[0005]

Means for Solving the Problems The present inventor has diligently searched for an effective material that can be ingested deliciously with meals and has a preventive meaning against obesity, and as a result, xyloglucan has an effect of improving lipid metabolism in the body, In other words, it has an effect of suppressing increase in body fat and an effect of suppressing increase in triglyceride level, cholesterol level, etc. in the liver as well as blood.
It has been found that it can be used as a prophylactic / therapeutic agent for hyperlipidemia.

A feature of the present invention is that when a high-cholesterol diet having an extremely high lipid content is taken with xyloglucan,
It is to suppress the absorption of lipids, especially cholesterol and triglyceride, and prevent the accumulation of lipids.

[0007] Xyloglucan is a polysaccharide present in the cell wall (primary wall) in which higher plants such as dicotyledons and monocotyledons are growing, and is used in tamarind, soybean, mung bean, common bean, rice, barley, apple and the like. Exists. It can also be obtained by cell culture of Sycamore, which is one of the Western maples.

Xyloglucan is a polysaccharide having glucose and xylose as main constituent sugars, and glucose has β1 as a main chain.
→ 4 linked, the side chain is mainly composed of xylose, and tamarind seed polysaccharide is one example. Xyloglucan is known to have a relatively low viscosity as compared with guar gum and locust bean gum.

The xyloglucan, which is the active ingredient of the present invention, may be xyloglucan of any origin, but xyloglucan derived from tamarind seeds, which has a large xyloglucan content and is easily available, is preferable. Tamarind seed polysaccharide has a structure in which xylose and galactose are bonded as side chains to the main chain composed of β-1,4-glucan, and is often used as a thickener for foods such as sauces and ice creams. There is.

As shown in the following test example, xyloglucan, which is an active ingredient of the present invention, has a remarkable inhibitory effect on lipid increase, that is, body fat, when a high-cholesterol diet having a high lipid content is ingested with xyloglucan. Since it has an inhibitory effect on increase and an inhibitory effect on not only blood but also increase in liver triglyceride level, cholesterol level, etc., if xyloglucan is taken alone or continuously added to various foods, obesity and high It is possible to prevent and treat lipemia and fatty liver. In addition, the texture is not impaired even if xyloglucan is added to food and ingested.

Examples of various foods include juices, lactic acid beverages, milk drinks, fermented milk, teas (green tea, black tea, oolong tea, etc.), frozen desserts (ice cream, sherbet, etc.),
Soups, frozen foods, powdered foods, sheet foods, bottled foods, canned foods, retort foods, pickles, smoked products, dried foods,
Tsukudani, salted products, meat products (hams, sausages, hamburgers, hamburger patties, meatballs, etc.), fish paste products (kamaboko, bamboo rings, fried fish, etc.), dairy products (butter, cheese, yogurt, processed milk, skim milk, etc.), Egg products (dashi roll, egg tofu, etc.), side dishes, breads, confectionery (cake, jelly, pudding, cream puff, candy, snacks, steamed buns, etc.), noodles (udon, soba, Chinese noodles, pasta, etc.), seasonings (Miso, soy sauce, sauce, ketchup,
Sauce, mayonnaise, etc.).

The dosage and method of administration of xyloglucan, which is the active ingredient of the present invention, include, for example, orally administering 0.5 to 5 g once to 3 times a day. Xyloglucan can be administered in the form of a preparation prepared by mixing with a carrier for preparation, or can be added to various foods and administered in the form of food. In particular, it can be added to dietary foods to obtain high-quality foods. For example, it can be contained in confectioneries, snacks, breads, noodles without difficulty in production. It can also be contained in liquid or jelly-like foods such as beverages, soups, frozen desserts and dessert foods, which have been difficult to add in the past.

Test Example Using a commercially available xyloglucan, the inhibitory effect on lipid increase was examined.

Six Wistar male rats (4 weeks old) were divided into two groups, a control group and a test group, and each group was fed with the feed (high fat diet) having the composition shown in Table 1 for 4 weeks ( 5% by weight of cellulose was added to the control group and 5% by weight of xyloglucan was added to the test group). During this time, feed and drinking water were freely available. After the breeding period, they were fasted overnight. Blood was collected from the abdominal aorta under Nembutal anesthesia, and then the liver was removed.

The collected blood was centrifuged (1100 g, 1
5 minutes), the supernatant, that is, plasma was obtained. This plasma was measured with an automatic analyzer (Hitachi: Hitachi-736) to determine each plasma component. The weight of the adipose tissue was determined by dissecting the adipose tissue in the abdominal cavity and measuring the weight. The feed efficiency was calculated by dividing the weight gain by the feed intake. The results are shown in Tables 2 and 3.

[0016]

[Table 1]

[0017]

[Table 2] ** p <0.01

[0018]

[Table 3] * P <0.05

From Table 2, in the xyloglucan intake group,
Although the feed efficiency is the same as the control group,
Adipose tissue is reduced by about 17% as compared with the control group, and it is clear that the increase in body fat is suppressed. Also, from Table 3, in the xyloglucan intake group, the total cholesterol and plasma triglyceride levels were reduced by about 35% and about 15%, respectively, compared to the control group,
An improvement in lipid metabolism is clearly seen. Also, for fatty liver, which is considered to be caused by a high fat diet load, the GOT value in the xyloglucan intake group was about 1 compared with the control group.
4% reduction, the effect is clear.

On the other hand, liver lipid was examined from the removed liver.

The extracted liver was homogenized while cooling with ice, 0.5 g of the homogenized mixture was taken, 5 ml of methanol and 10 ml of chloroform were added, and the mixture was stirred and centrifuged at 3000 rpm for 10 minutes to obtain a supernatant. The residue is stirred with chloroform / methanol (2: 1, v / v), the supernatant is recovered and combined with the previous supernatant. 20 ml of this supernatant was added to 0.
After adding 4 ml of 04% calcium chloride solution and shaking for 1 minute, centrifugation (3000 rpm, 10 minutes) was performed and the lower layer was washed with 3 volumes of 0.04% calcium chloride solution in 12 volumes of chloroform / methanol (2: 1). In addition, the mixture was shaken for 1 minute and then separated into two layers, and the supernatant was washed 3 times with 4 ml. The washed lower layer liquid was transferred to an Erlenmeyer flask, evaporated to dryness at 40 ° C., and further dried under reduced pressure for 9 hours. The weight was measured to determine the total lipid value per g of liver.

The total cholesterol level and triglyceride level were measured after the following pretreatment.

The extracted liver was homogenized while cooling with ice, 0.1 g of the liver was taken, 1.7 ml of methanol and 3.3 ml of chloroform were added, and the mixture was stirred and centrifuged (300).
0 rpm, 10 minutes). 1 ml of water was added to the supernatant, and the mixture was shaken and then centrifuged (3000 rpm, 10 minutes).
The lower layer was chloroform (2 ml), methanol (48 ml).
ml) and water (47 ml) mixed solution 0.2 ml.

The total cholesterol value is cholesterol E-
Test Wako (manufactured by Wako Pure Chemical Industries, Ltd.) and triglyceride value were measured and determined using Triglyceride G-Test Wako (manufactured by Wako Pure Chemical Industries, Ltd.). The results are shown in Table 4.

[0025]

[Table 4] * P <0.05; ** p <0.01.

From Table 4, in the xyloglucan intake group,
The total lipid, total cholesterol, and triglyceride levels in liver lipids were all significantly lower than those in the control group.

[0027]

The present invention will be specifically described below with reference to examples, but the present invention is not limited thereto.
As the xyloglucan, a commercially available product derived from tamarind seed (manufactured by Dainippon Pharmaceutical Co., Ltd .: trade name “Glyloid 3S”, “Glyloid 6C”) was used.

Example 1 Vegetable Juice Containing Xyloglucan: 0.5% by weight of xyloglucan (trade name "Glyloid 3S") was added to vegetable juice to prepare a vegetable juice containing xyloglucan. When this prepared vegetable juice was sampled, the concentration was increased as compared with the additive-free vegetable juice, which was preferable.

(Example 2) Jelly containing xyloglucan: Jelly containing xyloglucan (trade name "Glyloid 6C") and xyloglucan as a control were prepared by a conventional method according to the following jelly formulation (Table 5). Jelly not containing was prepared and tasted.

When xyloglucan was contained, a jelly with good elasticity and good texture was obtained, but when xyloglucan was not contained, gelling did not occur.

[0031]

[Table 5]

(Example 3) Waste jelly: jelly containing xyloglucan (trade name "Glyloid 6C") and jelly containing no xyloglucan as controls according to the following formula (Table 6) according to a conventional method. Was prepared and tasted.

The jelly containing xyloglucan had a good elasticity and a good texture.

[0034]

[Table 6]

Example 4 Soup containing xyloglucan: The following instant soup formulation (Table 7) was powder mixed and 200 ml of water was added to 21.5 g of this mixture.
The mixture was heated for 3 to 5 minutes with thorough mixing to prepare a powdered potage soup containing xyloglucan (trade name "Glyloid 3S") and a potage soup containing no xyloglucan, and sampled.

The soup containing xyloglucan showed almost no change in flavor and texture compared to the soup containing no xyloglucan, and was a preferable soup containing xyloglucan.

[0037]

[Table 7]

─────────────────────────────────────────────────── ─── Continuation of the front page (51) Int.Cl. ⁶ Identification code Internal reference number FI Technical display area A61K 31/715 ACN A61K 31/715 ADN ADN 35/78 C 35/78 A23L 2/00 F

Claims (2)

[Claims] 1. A lipid increase inhibitor containing xyloglucan as an active ingredient. 2. The lipid increase inhibitor according to claim 1, wherein the xyloglucan is xyloglucan derived from tamarind seed polysaccharide.